Global launch of LabVantage Biotech360: Powering Innovation, Driving Discovery

EVENT BROADCAST INFORMATION:

Wednesday, November 5th, 2025 (Click below to add broadcast to your calendar)

 Europe + Nordics + Middle East + Africa: 11:00am CET | 12:00pm EET

 North America + Brazil + Rest of Latam: 11:30am EDT | 12:30pm GMT-3 

Join LabVantage Solutions – 2024 Global LIMS company of the year by Frost & Sullivan – To discover how the newly launched LabVantage Biotech360 platform will help scientists uncover insights, reproduce results, and reduce the burden of finding the right information.

BioTech360 is a next-generation scientific intelligence platform designed to unify, contextualize, and accelerate life sciences research. It integrates experimental, sequence, and chemical data into a dynamic knowledge graph, transforming disconnected systems and datasets into actionable intelligence.

Powered by the SemantX semantic layer on TCG Digital’s mcube™ platform, BioTech360 enables AI-powered search, centralized sequence management, and dynamic analytics to accelerate discovery and ensure compliance.

Seamlessly connected with LabVantage LIMS, ELN, and external databases, BioTech360 empowers collaboration through secure workspaces and role-based access. It streamlines workflows, strengthens FDA/cGMP compliance, and speeds time to market—ushering in the next era of precision medicine and biologics.

Learning Objectives: 

•  Learn how BioTech360 unifies fragmented R&D data into a connected, contextualized platform for accelerated decisions.

• Understand how semantic technology and ontologies create dynamic knowledge graphs that link proprietary and public datasets for deeper insights.

• Explore how BioTech360 supports genomics, oncology, immunology, microbiology, and synthetic biology through specialized apps integrated with LabVantage LIMS.

• Discover how FAIR (Findable, Accessible, Interoperable, and Reusable) principles enhance transparency, reproducibility, AI-readiness, and collaboration across the R&D lifecycle.